IL1A and ovarian carcinoma: IL-1α, unlike IL-1β, was shown to exhibit anti-tumor properties through stimulation and activation of helper T cells, while IL-1β synthesized by ovarian cancer cells promoted increased invasiveness and facilitated the process of formation of secondary metastatic foci under the influence of proangiogenic factors (44).